Lyrica Approval History
FDA Approved: Yes (First approved December 30, 2004)
Brand name: Lyrica
Generic name: pregabalin
Dosage form: Capsules
Company: Pfizer Inc.
Treatment for: Neuropathic Pain, Postherpetic Neuralgia, Fibromyalgia, Diabetic Peripheral Neuropathy, Epilepsy
Lyrica (pregabalin) is a structural derivative of the inhibitory neurotransmitter gamma aminobutyric acid indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia and spinal cord injury; as an adjunctive therapy for partial onset seizures and for the treatment of fibromyalgia.
Development History and FDA Approval Process for Lyrica
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.